Objective: To compare methods for assessing changes in body composition during gonadal hormone replacement therapy in a group of HIV-positive men with AIDS wasting syndrome. Design: The study included a 21-day, double-blind, randomized, placebo-controlled inpatient intervention and a 12-week open-label intervention. The inpatient intervention included 18 men who were confined to a metabolic ward. Days 1-7 comprised weight stabilization and body composition measures followed by 14 days of nandrolone decanoate at either 65 or 195 mg weekly, or placebo, and repeat testing. The open-label intervention comprised 12 weeks of 200 mg nandrolone decanoate fortnightly with measurements of fat-free mass at 6 and 12 weeks. Methods: The inpatient intervention measured nitrogen balance from 24 h urine and fecal collections and fat-free mass by dual energy x-ray absorptiometry (DEXA), bioimpedance spectroscopy (BIS) and D 2 O dilution. Nitrogen balance was calculated as the difference between dietary intake and urinary and fecal nitrogen excretion. Nitrogen was converted to fat-free mass using the constant of 32.5 g. Repeated measures analysis of variance was used to determine which methods were significantly different from the reference nitrogen balance technique. Results: Nitrogen accretion of lean tissue was 0.55 and 0.85 kg weekly for low and high-dose groups, respectively. Estimated nitrogen retention during the open-label study was 0.42 kg weekly. Body weight increased with the estimated lean tissue accretion. DEXA, BIS and D 2 O methods demonstrated improvements in fat-free mass, although the BIS estimate of fat-free mass most closely matched the results of the nitrogen retention method. Conclusion: DEXA, BIS and D 2 O techniques demonstrated increases in fat-free mass. The BIS method is less costly, more convenient to use, and had results that more closely matched those from nitrogen balance and retention methods. BIS may be the preferred method to monitor changes in fat-free mass in AIDS patients and patients with malnutrition.
Introduction
Involuntary weight loss is a common AIDS-defining diagnosis, which is nearly universal in advanced AIDS [1, 2] . Fat-free mass (FFM) or body cell mass has a close relationship with survival in AIDS [3] [4] [5] [6] [7] . Treatment therapies using parenteral nutrition [8] and appetite stimulants [9] [10] [11] for patients with AIDS wasting syndrome have resulted mostly in repletion of body fat rather than FFM. A number of factors may contribute to the loss of the metabolically active FFM, which may include nutritional, metabolic/hormonal abnormalities including HIV itself, low protein and energy intake, malabsorption, and the catabolic effects of repeated infections [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Approximately 50% of HIV-infected men who demonstrate AIDS wasting syndrome also have borderlinelow serum testosterone levels (< 500 ng/dl). All the physiological consequences of borderline-low testosterone levels, such as acquired hypogonadism, in men with chronic wasting disorders are unknown. However, the low levels of testosterone may attenuate the effectiveness of any nutritional intervention therapy. Forbes [21] has shown that the effect of anabolic steroids on FFM follows a dose-response curve. At low doses the observed change in FFM was 1.5-3% of the initial value; this small amount falls within the precision of the techniques for measuring body composition. Large doses of anabolic steroids result in a progressive increase in FFM such that a total steroid dose of 2535 mg constitutes a dose that provides a significant increase in both nitrogen retention and FFM.
Kotler et al. [7] have demonstrated that a critical level of body cell mass must be maintained for survival; below this level death is imminent. Therefore, the ability to accurately monitor changes in body composition is important in the management of AIDS patients. Research by Sluys et al. [22] focused on the validity of bioimpedance analysis (BIA) for assessing total body water and FFM in AIDS patients, whereas Wang et al. [23] compared seven methods for measuring body fat in AIDS patients. The investigations by these two groups, however, did not attempt to monitor any changes in body composition during a course of treatment in AIDS patients receiving anabolic therapy. It was therefore the purpose of our study to determine the accuracy of three different body composition methodologies, each varying in expense and technical requirements, for assessing changes in FFM during gonadal hormonal replacement therapy in a group of HIV-positive men with AIDS wasting syndrome.
Design and methods

Research design
This clinical study consisted of two phases: phase A was a 21-day, double-blind, randomized placebo-controlled inpatient intervention, followed by phase B, which was a 12-week open-label intervention. Other aspects of this trial are reported in detail elsewhere [24] .
Phase A Men were confined to the metabolic research unit of the Western Human Nutrition Research Center. Seven days of weight stabilization and baseline measurements of body composition were followed by 14 days of nandrolone decanoate at either 65 or 195 mg per week, or placebo (sterilized sesame oil) administered by intramuscular injections, then repeat body composition testing. Staff and patients were blinded to the randomization.
To rapidly achieve steady-state plasma levels of nandrolone decanoate, a loading dose (240 mg for the high-dose group, 80 mg for the low-dose group, and sesame oil in the placebo group) was administered intramuscularly on the first treatment day. Injections of 19 or 56 mg nandrolone decanoate were administered every other day in the low and high dose groups, respectively.
Patients received a constant protein diet. Energy requirements were estimated using the Harris-Benedict equation with a physical activity factor of 1.5 [25] . Protein intake was 1.46 ± 0.02 g/kg daily. Energy from protein was 16.1 ± 0.4%, from carbohydrate 53.3 ± 0.5%, and from fat was 30.6 ± 0.2%. After achieving weight stability on a constant diet during the 7-day baseline period the treatment phase was started.
Weight was measured each morning after voiding and while wearing standardized clothing. Adverse clinical events were assessed by a physician. Prestudy exercise levels were maintained through two chaperoned walks of 1 km daily. No other exercise was permitted while in the metabolic research unit.
Phase B
During the 12-week open-label intervention, the men returned home and continued with normal daily activities. All 18 men were given nandrolone decanoate. Each man was required to report to the Western Human Nutrition Research Center fortnightly for administration of the drug therapy. Upon return to the center for intramuscular injections, follow-up measurements of body composition were made. Out of the 18 men completing the inpatient intervention, eight men completed 12 weeks of open-label intervention and all body composition procedures. The dose of nandrolone administered during the open-label phase was about one-half that given to the high-dose group during the inpatient phase (100 versus 195 mg per week) or 200 mg fortnightly. Reasons for withdrawal from the study included cytomegalovirus retinitis, chronic sinusitis, worsened lung disease, Pneumocystis carinii pneumonia, general deterioration, bacterial infection, new antiviral regimen, and relocation out of the area.
Subjects
Recruitment was through advertisements, by referral of health-care providers and from the AIDS wasting clinic at San Francisco General Hospital. Twenty-three men met the entrance criteria (HIV-seropositive, documented involuntary weight loss > 5% body weight, serum testosterone concentration < 25th percentile for age-group or < 33rd percentile with hypogonadal symptoms) and were enrolled in the study. Exclusion criteria were opportunistic infection within 60 days, oropharyngeal pathology, severe diarrhea, Karnofsky score < 50, use of medications with metabolic or nutritional effects (corticosteroids, marinol, theophylline, β-agonists, other anabolic agents), change in antiviral regimen within 30 days or use of experimental medications. All subjects were sedentary or light exercisers and none had received androgen treatment in the previous 6 months.
Amongst the 23 men enrolled in the study, the group mean (± SD) CD4 cell count was 90 ± 24 × 10 6 /l, documented weight loss was 13 ± 1%, and serum total testosterone was 382 ± 133 ng/dl. Of the initial 23 volunteers, 18 completed the 21-day inpatient intervention (seven in placebo group, four on low-dose nandrolone, seven on high-dose nandrolone). Two patients were discharged for non-compliance with specimen collection procedures, two left voluntarily due to inability to tolerate confinement, and one patient was disqualified for receiving a testosterone injection just prior to commencing the inpatient phase.
The research protocol was approved by the Institutional Review Boards of the University of California at San Francisco and the US Department of Agriculture. Each man was informed of the study objectives and procedures prior to giving his written consent.
Measurements
Nitrogen balance Twenty-four-hour urine and fecal collections were obtained from all men during the inpatient phase. Urine spills were quantified by using preweighed absorbent towels to wipe up the spilled urine (the difference between wet and dry towel weight was calculated as the amount of urine spilled). Total urinary nitrogen was analyzed by combustion (Nitrogen Determinator FP-428, LECO Corporation, St Joseph, Michigan, USA) [26] . Fecal samples were blended, aliquots were homogenized, lyophilized, crushed to a fine powder, dried, and analyzed for nitrogen content using the LECO analyzer. Nitrogen balance was calculated as the difference between dietary intake and the sum of urinary and fecal nitrogen excretion. Because of the variability in intestinal transit time due to intermittent diarrhea with or without the use of antimotility agents, the average daily value for fecal nitrogen measured during the baseline (first 7 days of phase A) or intervention (last 14 days of phase A) periods for each volunteer was used when calculating daily nitrogen balance. The mean baseline value was subtracted from the values during intervention to calculate the cumulative nitrogen retention. For each gram of nitrogen a corresponding value for FFM was calculated based on the constant of 32.5 g for the chemical composition of FFM [27] .
Body composition FFM was assessed by multifrequency bioimpedance spectroscopy (BIS 4000, Xitron Technologies, San Diego, California, USA) with spectra collected at 18 logarithmically spaced frequencies from 5 to 548 kHz. Impedance data were collected using standard procedures with impedance injection electrodes on the dorsal surfaces of the hand and foot at the distal metacarpals and metatarsals; sensing electrodes were positioned between the lateral and medial malleoli of the ankle and the distal prominence of the radius and ulna. The impedance and phase data from all frequencies were fitted to an equivalent Cole-Cole circuit model using non-linear curve-fitting procedures. The estimate of FFM was obtained using the Hanai equation, which is based on emulsion theory and is independent of any known reference value. This method has been previously used and validated in young adult men and women [28] , in women during pregnancy [29] , and under other clinical conditions [30, 31] .
Dual energy x-ray absorptiometry (DEXA, Lunar Corporation, Madison, Wisconsin, USA) was used to assess bone mineral content and bone-free lean tissue. The sum of these two compartments represented total FFM and has been found to be a valid estimation of FFM when compared with other methods [32] .
Total body water (TBW) was measured using deuterium oxide (D 2 O) dilution techniques. Each subject consumed a constant 20 g D 2 O cocktail (99.8% enriched). Respiratory water-vapor samples were collected before and after the ingestion of the cocktail (0, 3 and 4 h). Water vapor samples were analyzed using a Miran fixed filter (Foxboro Company, Foxboro, Massachusetts, USA) infrared spectrophotometer at a wavelength of 392 nm. TBW results were corrected for isotopic fractionation using the constant of Wong et al. [33] and adjusted for D 2 O dilution with non-aqueous hydrogen by 4%. Liters were converted to kilograms by multiplying by 0.9934 and to FFM using the constant of 0.73 for the TBW to FFM ratio. 
Statistical analysis
Descriptive statistics were used to characterize the subjects at the time of admission into the study. One-way analysis of variance (ANOVA) was used for comparing cumulative effects between groups. Repeated measures ANOVA was used for comparing changes in body composition over time. A significance level of P < 0.05 was used for all tests.
Results
Inpatient phase
Physical characteristics of the 18 men completing the inpatient phase are shown in Table 1 . At baseline there were no statistically significant differences in age, CD4 cell count, percentage of usual body weight, FFM, fat mass, Karnofsky score, or total testosterone amongst the three groups (Table 1) .
Nitrogen balance was not significantly different from zero in any group during the 7-day baseline period. However, during the 14-day intervention cumulative nitrogen balance for the three groups was significantly different ( Table 2) . During the first week of treatment the placebo group experienced an average nitrogen loss of 5.1 g, whereas the low and high-dose treatment groups experienced positive nitrogen balances of 15.6 and 24.4 g, respectively (Table 2) . Overall, during the 14-day intervention, the placebo group experienced a loss of nitrogen (−11.0 ± 10.7 g), whereas low and high-dose nandrolone decanoate treatment groups demonstrated increases in nitrogen balance of 33.4 ± 11.2 and 52.3 ± 10.7 g, respectively ( Table 3 ). Assuming that each gram of nitrogen retained corresponds to an accretion of 32.5 g FFM, the highdose treatment group experienced a gain of 0.85 ± 0.18 kg FFM per week, the low-dose treatment group averaged 0.55 ± 0.18 kg FFM week, and the placebo group had a loss of 0.18 ± 0.10 kg FFM per week (Table 3) . Values for lean tissue were calculated using the constant of 1 g nitrogen = 32.5 g lean tissue [27] . Cumulative lean tissue change calculated from cumulative nitrogen balance change. intervention, the increase in body weight was slower and greater increases were observed in FFM (Table 5) 
Open-label phase
Discussion
Borderline hypogonadism occurs in a variety of clinical conditions and is characterized by weight loss, infection, or stress. Decreased reproductive function may be adaptive in many animal models during food scarcity, although the functional significance in humans and clinical reversibility observed in chronic wasting disorders is uncertain.
Previous investigators [1, 7] have shown that body cell mass is depleted in HIV-positive patients with AIDS wasting syndrome. Depletion of body cell mass is characterized by a low body weight (< 10%) and low total body potassium, independent of body fat levels. The average value for percentage of usual body weight was 86-87% for the present investigation and body fat ranged from 13 to 20%. Kotler et al. [1] have also demonstrated an increased extracellular fluid volume (ECF) in patients with AIDS wasting syndrome or a relative overhydration of the ECF compartment compared with TBW. These results would suggest that a technique that can distinguish ECF from TBW might be useful in monitoring patient progress.
As a follow-up to the studies by Kotler et al., Wang et al. [23] used a variety of body composition techniques to assess body composition (specifically body fat) in HIV-positive men. Using in vivo neutron activation (IVNA) as the reference method, Wang et al. [23] demonstrated that all methods were significantly correlated. However, in the computation of FFM by IVNA a measurement is needed for TBW, and tritium dilution was therefore used for this purpose. Consequently, the relationship between IVNA and tritium dilution as a separate independent measure of body composition was confounded. Another difficulty with the results of Wang et al. [23] was the use of single frequency BIA, which cannot separate ECF from TBW. Therefore, an increase in ECF would be interpreted as a general increase in TBW and thus FFM, the net result being a lower estimate of fat mass. The research of Kotler et al. [1] and Wang et al. [23] was useful in that they demonstrated a depletion in body cell mass and its association with time of death. They did not, however, use different methodologies to monitor changes in patients during the course of therapy.
Sluys et al. [22] used multiple isotope dilution techniques to estimate TBW, exchangeable sodium and potassium, and body cell mass. These measurement techniques were compared with results obtained from BIA. Again, a strong relationship was observed amongst the methods, but once again the measurements were made under static conditions and not longitudinally during a course of therapy.
The test of any method for body composition assessment in a clinical setting, however, must coincide with a treatment regimen, and it must be able to assess change in patient status. [37] examined body composition of adult men using both Lunar and Hologic DEXA instruments. Both instruments gave the same result for total body mass; however, Lunar DEXA gave lower values for body fat and higher values for FFM compared with Hologic DEXA. The lower fat mass by Lunar DEXA was about 2 kg, whereas FFM was higher by about 2 kg. The differences in these body composition parameters were due to differences in the trunk region. The findings of Modlesky et al. [37] were similar to those in our investigation, namely that DEXA consistently gave lower body fat values and higher FFM values than either BIS or D 2 O dilution methods.
Of the methods used in our study, BIS has been evaluated using healthy men and women [28] and under clinical conditions such as pregnancy [29] , in growth hormone-deficient adults [30] , and in progressive cellular dehydration [31] . In the case of pregnancy [29] , BIS estimates of TBW and ECF were not significantly different from those obtained by D 2 O and bromide dilution methods at any time throughout pregnancy. Van Marken Lichtenbelt et al. [30] used D 2 O and bromide dilution methods as the standard techniques for assessment of ECF and TBW in growth hormone-deficient adults. Results from the dilution techniques were confirmed by BIS measurements. Thus, BIS provided an accurate estimate of both ECF and TBW compared with standard dilution methods. In a study of progressive cellular dehydration and proteolysis in critically ill patients, Finn et al. [31] also used standard dilution techniques to monitor ECF and TBW. BIS was used as well as whole-body neutron activation analysis and whole-body potassium counting. Over the course of the study, intracellular fluid decreased by 15-20%, total body protein by 15%, and total body potassium by about 20%. Intracellular fluid was calculated as TBW minus ECF. There was a substantial decline in ECF (5.9 l by bromide dilution); similarly, BIS demonstrated a decline of 5.87 l. In all these studies, the investigators demonstrated that BIS was able to distinguish extracellular fluid from TBW. It is the distinction of these fluid compartments that is critical in the accurate assessment of changes in body composition. Based on the nitrogen balance and retention data, our study demonstrated that the BIS method most closely matched the changes in lean tissue accretion in men with AIDS wasting syndrome undergoing anabolic therapy and is therefore a valid method for monitoring changes in body composition.
In conclusion, body composition assessment was performed using nitrogen balance and retention as well as DEXA, BIS, and D 2 O dilution in a group of HIVpositive men treated for AIDS wasting syndrome. All of the methods demonstrated an improvement of FFM with nandrolone decanoate intervention. However, changes in FFM, based on nitrogen balance and retention data, during the course of nandrolone decanoate therapy were most closely matched by BIS. Based on previous research, the ability of BIS to distinguish ECF from TBW may be the underlying reason for the greater accuracy in monitoring changes in body composition.
